Nearly all individuals with intellectual and developmental disabilities experienced improvement in tardive dyskinesia severity after starting INGREZZA, and of those, 89% experienced improvement...

Data being presented, including six oral presentations, reinforce AbbVie's leadership and commitment to ongoing research to improve outcomes for people living with blood cancers NORTH CHICAGO,...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, has been selected to present Phase II updated results for BW-20805 at the...

-- FDA-cleared device minimizes CT/MRI artifacts, remains radiopaque under fluoroscopy -- BOULDER, Colo., June 8, 2026 /PRNewswire/ -- Embolization, Inc., will present its novel embolization...

This is a report from China.org.cn Video Link: https://youtu.be/9NLo7nKtGo8 The China International Supply Chain Expo, or CISCE, showcases not only finished products but also the networks of...

Innodisk, a leading global AI solution provider, showcases the full breadth of its collaboration with Qualcomm Technologies, Inc. at Computex 2026. Building on the "AI on Dragonwing" computing...

The 23rd China International Hardware Show (CIHS 2026), recognized as Asia's premier and most influential professional hardware sourcing platform, will take place from September 28 to 30, 2026, at...

CagriSema, a once-weekly investigational treatment that combines a novel amylin analog with a GLP-1 receptor agonist (RA), achieved significant reductions in HbA1c and bodyweight versus...

VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes New Real-World Data Highlight Treatment Gaps in...

Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA), asthma-related adverse outcomes, liver health, cardiometabolic risk...